HealthDay News — Compared with manual screening, an artificial intelligence (AI)-assisted patient screening tool can improve the rate of eligibility determination and enrollment for randomized ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology ...

The promise of AI in drug discovery has fueled big business for the pharmaceutical industry with new AI drug companies smashing funding records one after another and new partnerships between big ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. Launched in ...

Contract research organisation (CRO) Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies. This service aims to “segment” subject populations ...

Mathematicians have invented a new statistical tool to analyze multiple outcomes from clinical trials, replacing the 60-year-old standard tool that could only look at binary outcomes (survived/ did ...

Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...

Implementing AI-assisted screening tool enhances clinical trial efficiency, expedites screening process. (HealthDay News) — Compared with manual screening, an artificial intelligence (AI)-assisted ...